Spots Global Cancer Trial Database for metoclopramide
Every month we try and update this database with for metoclopramide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin | NCT01093690 | Cancer | metoclopramide placebo | 18 Years - | Mahidol University | |
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin | NCT01093690 | Cancer | metoclopramide placebo | 18 Years - | Mahidol University | |
MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy | NCT02135510 | Solid Tumors | metoclopramide dexamethason palonosetron | 18 Years - | Amsterdam UMC, location VUmc | |
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas | NCT01851369 | Lymphomas Solid Tumors NSCLC Metastatic Colo... Granulosa Cell ... | TRC102 CT scan Lomotil Prochlorperazin... Metoclopramide 5-HT3 antagonis... Aprepitant Biopsy | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
Treatment Algorithm for Nausea and Vomiting in the Palliative Phase | NCT03017391 | Nausea Vomiting Cancer | metoclopramide granisetron Dexamethasone Granisetron 2Mg... | 18 Years - | Radboud University Medical Center | |
Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS) | NCT00120653 | Myelodysplastic... | Metoclopramide | 18 Years - 72 Years | National Institutes of Health Clinical Center (CC) | |
MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy | NCT02135510 | Solid Tumors | metoclopramide dexamethason palonosetron | 18 Years - | Amsterdam UMC, location VUmc | |
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas | NCT01851369 | Lymphomas Solid Tumors NSCLC Metastatic Colo... Granulosa Cell ... | TRC102 CT scan Lomotil Prochlorperazin... Metoclopramide 5-HT3 antagonis... Aprepitant Biopsy | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
Palliative Management of Inoperable Malignant Bowel Obstruction | NCT04027348 | Malignant Bowel... | Dexamethasone Metoclopramide Octreotide | 18 Years - | Roswell Park Cancer Institute | |
Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure | NCT02481219 | Colorectal Canc... | PillCam® COLON ... Senna tablets PEG Metoclopramide Erythromycin SUPREP oral sul... Bisacodyl SUPREP oral sul... | 50 Years - 75 Years | Medtronic - MITG | |
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. | NCT06379217 | Metastatic Neur... | [68Ga]Ga-PSMA-1... [68Ga]GA-DOTA-T... [68Ga]Ga-NeoB [177Lu]Lu-PSMA-... [177Lu]Lu-DOTA-... [177Lu]Lu-NeoB L-Lysine HCl-L-... Gonadotropin-re... GnRH antagonist... Antiemetics & a... Metoclopramide | 18 Years - | Novartis |